AGBL2 and rheumatoid arthritis: However, where the CCP1 assay is based on a filaggrin-derived peptide, the CCPs used in the CCP2 assay reportedly do not correspond to any human protein sequence, and thus the CCP2 antibodies only act as surrogate markers for autoimmunity in RA without formally defining any reactivity against autoantigens present in vivo.